RNN Rexahn Pharmaceuticals Inc.

$1.6 -1.84%

61,728 Shares Traded
300,340 Average Volume (last 30 days)

as of March 23, 2018 EST IEX Real-Time Price

Short Pain Metrics

Approximate Amount of Money Shorts Have Made on the Day: $48.01 thousand
If Intiated on the First, Shorts Have Realized a Year to Date Return of:22.38%
If Intiated One Month Ago, Shorts Have Realized a Return of:6.32%
If Initiated Five Days ago, Shorts Have Realized a Return of:2.4%
Peer Potential Short Squeezes Near Real Time Screener
*Please note the actual returns of shorts could be different as they started from different points

Daily Indicators

Daily Short Pain Indicator [i] - Always Use Fundamentals on EverythingNeutral
200 Day Moving Average Indicator Bearish
50 Day Moving Average Indicator Bearish
52 Week High/Low Indicator Neutral

Short Stats

Short Percent to Float 7.72%
Short Interest1.6 million
Float20.72 million
Short Ratio4.93
Market Cap$51.74 million
Market Maker ActivityDaily Short Volume


Your Daily Pharma Scoop: Akebia Update, Rexahn Data, Concert Commences Enrollment (SeekingAlpha)
Rexahn's RX-3117 shows positive effect in mid-stage bladder cancer study (SeekingAlpha)
Premarket Gainers as of 9:05 am (02/12/2018) (SeekingAlpha)
Week In Review: Tsinghua University Invests $276 Million In Cambridge U.K. Biohub (SeekingAlpha)
Rexahn Pharma teams up with Zhejiang Haichang Bio to develop RX-0201 for liver cancer; shares up 1% premarket (SeekingAlpha)
Rexahn nabs U.S. patent protecting Supinoxin; shares ahead 2% premarket (SeekingAlpha)
Midday Gainers / Losers (1/19/2018) (SeekingAlpha)
Rexahn Pharmaceuticals (RNN) Presents At Stifel 2017 Healthcare Conference - Slideshow (SeekingAlpha)
Mid-stage study underway assessing Rexahn's RX-3117 in pancreatic cancer (SeekingAlpha)
Rexahn Pharmaceuticals reports Q3 results (SeekingAlpha)

Smart Money Sentiment

Institutional Ownership (Top 15 Funds) 4.5%

Earnings Stats

PE Ratio -2.66
Dividend Yield 0%
Peer EarningsEarnings Calendar


200 Day Moving Average $2.2
50 Day Moving Average $1.9
52 Week High $7.1
52 Week Low $1.51

Data provided for free by IEX. Questions? Read the FAQ